A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Colchicine (Colcrys)

an alkaloid indicated for: • Prophylaxis and treatment of gout flares in adults ( 1.1 ). • Familial Mediterranean fever (FMF) in adults and children 4 years or older ( Error! Hyperlink reference no....

First FDA approval2009-09-01
Generic availableYes · 14 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$124.2M in CY2024 Part D spend2.3M claims · 1.1M beneficiaries · 329 plans surveyed

Lowest NADAC
$0.123/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.123
Across all dosage forms in distribution.
Highest NADAC
$0.123
Range is tight.
Plans with PA
1 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Colchicine used for?

an alkaloid indicated for: • Prophylaxis and treatment of gout flares in adults ( 1.1 ). • Familial Mediterranean fever (FMF) in adults and children 4 years or older ( Error! Hyperlink reference no....

Is there a generic for Colchicine?

Yes. 18 ANDAs filed at FDA, 14 generic manufacturers currently shipping.

How much does my plan pay for Colchicine?

Across 329 Part D plans, Colchicine averages $0.123/unit (NADAC). Lowest available: $0.123/unit. Highest in distribution: $0.123/unit.

Is Colchicine on the FDA shortage list?

No. Colchicine is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Alkaloid2 alternatives in D1
01
Colchicine Tablets
Brand: LODOCO
$17.00Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Probenecid and Colchicine
Alkaloid
$0.805Lowest NADAC
3Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.